Basel, Switzerland

Daniel Vincent Fishlock

This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Hoffmann-La Roche Inc., F. Hoffmann-La Roche Ag. Active years: 2015-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniel Vincent Fishlock. Retrieved from https://idiyas.com/inventor/daniel-vincent-fishlock

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 75.0

 

 

Average Co-Inventor Count = 5.8

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2015-2024

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Daniel Vincent Fishlock - Innovative Inventor from Basel

Introduction: Daniel Vincent Fishlock is a renowned inventor based in Basel, Switzerland, known for his groundbreaking contributions to various industries.

Latest Patents: Daniel Vincent Fishlock holds several patents in the fields of biotechnology, renewable energy, and medical devices, showcasing his diverse range of expertise.

Career Highlights: With over two decades of experience in the innovation sector, Fishlock has successfully developed and commercialized numerous inventions that have had a significant impact on society.

Collaborations: Throughout his career, Daniel Vincent Fishlock has collaborated with leading research institutions, universities, and companies worldwide to bring his ideas to life and create tangible solutions to complex problems.

Conclusion: Daniel Vincent Fishlock's passion for innovation and his relentless drive to push the boundaries of what is possible make him a true pioneer in the world of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…